ArticleEBioMedicine2020

Corrigendum to 'PRAS40 hyperexpression promotes hepatocarcinogenesis' [EBioMedicine 51 (2020) 102,604].

Zhaolai Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.